Sutro Biopharma, Inc.
NASDAQSTRO short interest climbs 20.5% over one week to 1.16% of float, driven by biotech sector momentum. Cost to borrow falls to 0.99% as shares remain abundantly available.
Snapshot as of 28 Jun 2026
No long-form analysis yet for STRO. Pulse alerts and the live data picture are available on ORTEX.
Open STRO on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for STRO — free to start on ORTEX.
Sign up for free →Open STRO on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live STRO data →